Others

Cadila Healthcare Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

| Updated on August 02, 2019 Published on August 02, 2019

Zydus Announces Completion of Phase III trials of Saroglitazar Magnesium in Type 2 Diabetes Mellitus

Pdf Link: Cadila Healthcare Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Source : BSE - www.bseindia.com

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on August 02, 2019
This article is closed for comments.
Please Email the Editor